744.9500 -8.95 (-1.19%)
NSE Aug 07, 2025 15:30 PM
Volume: 435.7K
 

Axis Direct
we maintain a BUY rating with a target price of Rs 615/share with a valuation of 21x EV/EBITDA for Sep 27E. The TP implies an upside potential of 10% from the CMP.
Number of FII/FPI investors increased from 226 to 257 in Jun 2025 qtr.
More from Krishna Institute of Medical Sciences Ltd.
All Rapid Results
Recommended